Brief: Immunovia Q4 Revenue SEK 155 Thousand

Immunovia AB (publ)

21/02/2024 07:30

Feb 21 (Reuters) - Immunovia Q4 adjusted free cash flow SEK -28 million.
* Q4 adjusted EPS SEK -1.08
* Q4 net income SEK -49 million